MYCN and neuroblastoma: To evaluate the efficacy of vertical inhibition along the USP7-MDM2–p53 pathway in NB cells, we studied the efficacy of treatment with Almac4 combined wit- MDM2 inhibition with Nutlin-3 in MYCN-amplified, TP53 wild-type NB cell lines sensitive to Almac4 treatment.